A microfluidic liquid phase microextraction method for drugs and parabens monitoring in human urine
Frequent consumption of pharmaceuticals and personal care products (PPCPs) have emerged as a current problem that highlights the pressing need for new multi-residue analytical methods that allow their simultaneous determination to assess their overall effect on human health. In this regard and for t...
| Autores: | , , , |
|---|---|
| Formato: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2021 |
| País: | España |
| Recursos: | Universidad de Sevilla (US) |
| Repositorio: | idUS. Depósito de Investigación de la Universidad de Sevilla |
| OAI Identifier: | oai:idus.us.es:11441/128170 |
| Acesso em linha: | https://hdl.handle.net/11441/128170 https://doi.org/10.1016/j.microc.2021.106577 |
| Access Level: | acceso abierto |
| Palavra-chave: | Microfluidic device Liquid phase microextraction High pressure liquid chromatography-UV Metabolites Parabens Drugs Human urine |
| Resumo: | Frequent consumption of pharmaceuticals and personal care products (PPCPs) have emerged as a current problem that highlights the pressing need for new multi-residue analytical methods that allow their simultaneous determination to assess their overall effect on human health. In this regard and for the first time, a versatile microfluidic based- liquid phase microextraction (LPME) method was developed for simultaneous monitoring of ten compounds from six different classes: amoxicillin, sulfadiazine, sulfamerazine, tiamphenicol, ethyl 4-hydroxybenzoate, flumequine, propyl 4-hydroxybenzoate, 5-hydroxydiclofenac, 3-hydroxydiclofenac and diclofenac. The microfluidic device was combined with a HPLC-UV system for the separation and determination of the model analytes in the sample. Optimal conditions were reached using 2-nitrophenyl octyl ether as supported liquid membrane, pH 3.5 as donor phase, pH 11.5 as acceptor phase, 0.5 µL min−1 as donor flow rate and 1 µL min−1 as acceptor flow rate. Under optimal method conditions, the extraction efficiency was between 85 and 100% for most compounds after 10 min extraction, and it was successfully applied in non-diluted human urine, with recoveries between 70 and 100% for all analytes except for sulfamerazine (52% recovery). In addition, the extraction of metabolites (3-hydroxydiclofenac and 5-hydroxydiclofenac) was also demonstrated in microfluidic systems with recoveries between 71 and 100% in human urine. The proposed method allowed consecutive extraction and only requires 5 µL of organic solvent and less than 15 µL of sample volume. |
|---|